20-31823495-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_033118.4(MYLK2):​c.791C>T​(p.Pro264Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000788 in 1,613,344 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P264P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0015 ( 3 hom., cov: 33)
Exomes 𝑓: 0.00071 ( 11 hom. )

Consequence

MYLK2
NM_033118.4 missense

Scores

1
11
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 2.99

Publications

6 publications found
Variant links:
Genes affected
MYLK2 (HGNC:16243): (myosin light chain kinase 2) This gene encodes a myosin light chain kinase, a calcium/calmodulin dependent enzyme, that is exclusively expressed in adult skeletal muscle. [provided by RefSeq, Jul 2008]
MYLK2 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy 1
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009515107).
BP6
Variant 20-31823495-C-T is Benign according to our data. Variant chr20-31823495-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 164504.
BS2
High AC in GnomAd4 at 235 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYLK2NM_033118.4 linkc.791C>T p.Pro264Leu missense_variant Exon 5 of 13 ENST00000375985.5 NP_149109.1 Q9H1R3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYLK2ENST00000375985.5 linkc.791C>T p.Pro264Leu missense_variant Exon 5 of 13 1 NM_033118.4 ENSP00000365152.4 Q9H1R3
MYLK2ENST00000375994.6 linkc.791C>T p.Pro264Leu missense_variant Exon 4 of 12 1 ENSP00000365162.2 Q9H1R3

Frequencies

GnomAD3 genomes
AF:
0.00154
AC:
235
AN:
152248
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000289
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0183
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000544
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00155
AC:
387
AN:
250306
AF XY:
0.00148
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0156
Gnomad NFE exome
AF:
0.000415
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
AF:
0.000710
AC:
1037
AN:
1460978
Hom.:
11
Cov.:
31
AF XY:
0.000666
AC XY:
484
AN XY:
726796
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86252
European-Finnish (FIN)
AF:
0.0164
AC:
861
AN:
52548
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.000123
AC:
137
AN:
1111988
Other (OTH)
AF:
0.000629
AC:
38
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
54
108
162
216
270
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00154
AC:
235
AN:
152366
Hom.:
3
Cov.:
33
AF XY:
0.00217
AC XY:
162
AN XY:
74512
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41590
American (AMR)
AF:
0.00
AC:
0
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.000289
AC:
1
AN:
3466
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.0183
AC:
195
AN:
10632
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000544
AC:
37
AN:
68034
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
12
24
35
47
59
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000451
Hom.:
2
Bravo
AF:
0.0000793
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00118
AC:
143
EpiCase
AF:
0.000109
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jul 10, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant classified as Uncertain Significance - Favor Benign. The Pro264Leu varia nt in MYLK2 has not been previously reported in individuals with cardiomyopathy, but has been identified in 2/8600 European American chromosomes by the NHLBI Ex ome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs142620954). P roline (Pro) at position 264 is not conserved in evolutionarily distant species and 7 fish species carry a leucine (Leu) at this position, raising the possibili ty that this change may be tolerated. In summary, while the clinical significanc e of the Pro264Leu variant is uncertain, the presence of the variant amino acid in several species indicates it is more likely benign. -

not provided Benign:1
Mar 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypertrophic cardiomyopathy 1 Benign:1
Aug 14, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.34
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.60
D;D
Eigen
Uncertain
0.32
Eigen_PC
Uncertain
0.26
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Uncertain
0.90
.;D
MetaRNN
Benign
0.0095
T;T
MetaSVM
Uncertain
-0.21
T
MutationAssessor
Uncertain
2.3
M;M
PhyloP100
3.0
PrimateAI
Uncertain
0.59
T
PROVEAN
Pathogenic
-7.7
D;D
REVEL
Benign
0.25
Sift
Uncertain
0.0070
D;D
Sift4G
Uncertain
0.029
D;D
Polyphen
0.97
D;D
Vest4
0.41
MVP
0.73
MPC
0.28
ClinPred
0.23
T
GERP RS
3.8
Varity_R
0.28
gMVP
0.48
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142620954; hg19: chr20-30411298; COSMIC: COSV65658543; COSMIC: COSV65658543; API